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N6-methyladenosine (m6A) has been recently identi-
fied as a conserved epitranscriptomic modification
of eukaryotic mRNAs, but its features, regulatory
mechanisms, and functions in cell reprogramming
are largely unknown. Here, we report m6A modifi-
cation profiles in the mRNA transcriptomes of four
cell types with different degrees of pluripotency.
Comparative analysis reveals several features of
m6A, especially gene- and cell-type-specific m6A
mRNA modifications. We also show that microRNAs
(miRNAs) regulate m6A modification via a sequence
pairing mechanism. Manipulation of miRNA expres-
sion or sequences alters m6A modification levels
through modulating the binding of METTL3 methyl-
transferase to mRNAs containing miRNA targeting
sites. Increased m6A abundance promotes the
reprogramming of mouse embryonic fibroblasts
(MEFs) to pluripotent stem cells; conversely, re-
duced m6A levels impede reprogramming. Our
results therefore uncover a role for miRNAs in regu-
lating m6A formation of mRNAs and provide a
foundation for future functional studies of m6A modi-
fication in cell reprogramming.
INTRODUCTION
More than 100 types of post-transcriptional modifications have
been identified in RNAs so far (Cantara et al., 2011; Globisch
et al., 2011; He, 2010), among which N6-methyladenosine
(m6A) RNA methylation is one of the most prevalent modifica-
tions of messenger RNAs (mRNAs) (Desrosiers et al., 1974;
Wei et al., 1975). m6A accounts for about 50% of total methyl-Cated ribonucleotides and is present in 0.1%–0.4% of all adeno-
sines in total cellular RNAs (Desrosiers et al., 1974; Wei et al.,
1975). In vivo, the formation of m6A is catalyzed by a multi-
component methyltransferase complex with at least three pro-
teins, namely methyltransferase-like 3 (METTL3), METTL14,
and Wilms’ tumor 1-associating protein (WTAP) (Bokar et al.,
1997; Finkel and Groner, 1983; Liu et al., 2014; Ping et al.,
2014; Schwartz et al., 2014; Wang et al., 2014b). The m6A
modification can be removed by RNA demethylases, of which
the two known ones are fat mass and obesity-associated pro-
tein (FTO) and alkylated DNA repair protein alkB homolog 5
(ALKBH5) (Jia et al., 2011; Zheng et al., 2013). So far, two
YTH (YT521-B homology)-domain containing proteins, YTHDF2
and YTHDC1, have been identified to specifically recognize
m6A-modified RNAs (Dominissini et al., 2012; Xu et al., 2014;
Zhu et al., 2014).
In general, m6A modification can be detected in the mRNAs
of over 7,000 genes in mammalian cells, and it tends to occur
at the consensus RRACH motif (R = G or A; H = A, C, or U)
(Bodi et al., 2010; Dominissini et al., 2012; Harper et al., 1990;
Meyer et al., 2012; Wei and Moss, 1977). On average, the fre-
quency of m6A modification is about one peak per 2,000 nucle-
otides (nts), but there are also some regions with clustered m6A
peaks (Dominissini et al., 2012; Kane and Beemon, 1985; Meyer
et al., 2012). Strong enrichment of m6A modification has been
found near the stop codons of mRNAs (Dominissini et al.,
2012; Meyer et al., 2012).
Although the existence of m6A does not change the coding
capacity or base pairing of adenine with uracil or thymine, it
may block the nonstandard A:G base pairing and influence
RNA structures (Dai et al., 2007). The presence of m6A may
also affect the expression level, translation efficiency, nuclear
retention, splicing, and stability of mRNAs (Camper et al.,
1984; Finkel and Groner, 1983; Fustin et al., 2013; He, 2010;
Hess et al., 2013; Liu et al., 2014; Ping et al., 2014; Schwartz
et al., 2013; Tuck et al., 1999; Wang et al., 2014a, 2014b;
Zhao et al., 2014; Zheng et al., 2013). Deficiency of m6Aell Stem Cell 16, 289–301, March 5, 2015 ª2015 Elsevier Inc. 289
formation has been proven to affect circadian rhythm, cell
meiosis, and embryonic stem cell (ESC) proliferation, and thus
it is implicated in obesity, cancer, and other human diseases
(Batista et al., 2014; Dominissini et al., 2012; Geula et al.,
2015; He, 2010; Liu and Jia, 2014; Liu et al., 2013; Machnicka
et al., 2013; Meyer et al., 2012; Niu et al., 2013; Sibbritt et al.,
2013). However, the regulatory mechanisms of m6A formation
and the function of m6A in regulating cell reprogramming are still
largely unknown.
Here we examined the transcriptome-wide distribution of
m6A modification in mouse ESCs, induced pluripotent stem
cells (iPSCs), neural stem cells (NSCs), and testicular sertoli
cells (SCs). Our results identified the difference in m6A distri-
bution between pluripotent and differentiated cell types. We
discovered that the m6A formation of mRNAs is regulated by
microRNAs (miRNAs) via a sequence pairing mechanism, and
we revealed m6A as a positive regulator for cell reprogramming
to pluripotency.
RESULTS
General Features of m6A Distribution in Mouse
Pluripotent and Differentiated Cell Lines
To investigate the features and distribution dynamics of mRNA
m6A modification in different cell types, we performed m6A-
seq using mouse ESCs, iPSCs, NSCs, and SCs. In total,
33,000–43,000 m6A-enriched regions, also known as m6A
peaks, were identified on mRNAs of 7,000–8,000 expressed
genes in each cell type. Using m6A-qRT-PCR, 13 out of 15
randomly selected m6A peaks were verified in all cell types (Fig-
ures S1A and S1B), implying a high authenticity of our data.
Genes encoding transcripts with m6A modifications involved in
many essential biological processes, including transcription
regulation, chromatin modification, cell cycle control, apoptosis,
etc., amongwhich transcripts encoding proteins for DNA binding
activity were identified as the most significantly enriched group
(counted for over 10% of m6A-modified genes) (Figure S1C, Ta-
ble S1, and Table S2).
Similar to previous reports (Dominissini et al., 2012; Meyer
et al., 2012), we also observed a tendency toward m6A distribu-
tion in the coding sequence (CDS) region of mRNAs, with a
strong enrichment around the translation termination sites
(TsTS) in all four examined cell types (Figure S1D). Transcripts
of majority genes (ESCs, 77%; iPSCs, 72%; NSCs, 63%; SCs,
74%) each harbored fewer than five m6A peaks, yet there were
transcripts of some genes (ESCs, 9%; iPSCs, 4%; NSCs,
12%; SCs, 6%) with over 50% of their lengths covered by m6A
peaks (Figure S1E); we thus named these ‘‘m6A high-coverage
transcripts.’’ The length of these m6A high-coverage transcripts
did not differ significantly from that of the overall transcripts, and
some of these transcripts encoded proteins involved in the regu-
lation of processes essential for the maintenance of cell-type
specific features, such as neuron differentiation and develop-
ment in NSCs (Table S3).
Common and Cell-Type-Specific m6A Modification
Using the Shannon-entropy-based method (Xie et al., 2013), we
identified a total of 8,558 genes with stable expression in all
examined cell types (Table S4). Among them, only transcripts290 Cell Stem Cell 16, 289–301, March 5, 2015 ª2015 Elsevier Inc.of 3,880 genes had m6A modifications in all samples and
were enriched in essential biological processes (Figure 1A and
Table S4). On the other hand, transcripts of 1,087 stably
expressed genes had no m6A modification in any examined
cell type, and the functions of these genes tended to relate to
the synthesis and functional establishment of proteins (Figure 1B
and Table S4).
To study the m6A modification profiles across cell types, we
further divided each transcript into TcSS (transcription start
sites), 50 UTR, CDS, TsTS (translation termination sites), and 30
UTR regions and compared the m6A distribution profile within
each region. m6A modifications in CDS and TsTS regions were
more conserved across cell types than those in other regions,
with about 50% transcripts having m6A modifications in the
CDS and TsTS regions in all examined cell types; yet, only less
than 5% of m6A modifications in the TcSS and 50 UTR regions
were conserved across cell types (Figures 1C and 1D and Table
S4). At the transcript level, only 437 (11% of 3,880) transcripts
had consistent m6A distribution profiles in all examined samples
(Figure 1C), and the rest of the transcripts (3,443; 89% of 3,880)
had variable m6A peaks in at least two cell types (Figure 1D).
A total of 1,695 genes were identified as cell-type-specif-
ically expressed, of which 998 genes had transcripts with
m6A modifications (Figure 1E and Table S5). In addition, among
the 8,558 genes with stable expression in all cell types, the
transcripts of 877 genes had cell-type-specific m6A modifica-
tions. Gene ontology analysis revealed transcripts with cell-
type-specific m6A modifications involved in many cell-type-
specific biological processes, such as stem cell maintenance
and developmental regulation in ESCs and iPSCs, as well as
neuron differentiation and forebrain development regulation in
NSCs (Table S5). As expected, many known cell-type specific
markers were among these genes, including key transcription
factors essential for specific features of each cell type, such
as Oct4, Nanog, and DPPA2 for ESCs and iPSCs; POU3F2
and ROBO2 for NSCs; and DHH and Sox8 for SCs (Figures
1E and S1F).
m6A Peaks Are Enriched at miRNA Target Sites
To investigate the sequence features of m6A methylation sites,
we performed motif search among m6A regions of all cell types.
More than 87% of identified m6A peaks contained the previ-
ously reported RRACH motif, with GGACU as the most
frequent motif in all examined cell types (Figure 2A). The enrich-
ment of the RRACH motif among m6A peaks was significantly
higher than that among the control peaks (p < 2.2e16,
Fisher’s exact test). In addition, we also identified a few other
motifs (ESCs: 15; iPSCs: 9; NSCs: 8; SCs: 12) within 87%–
99% of m6A peak regions (Figures S2A–S2D). Intriguingly, we
found that the RRACH motif and over two-thirds (67%–89%,
depending on the cell type) of the identified motifs were
reversely complementary to the seed sequences (50 2-8 nucle-
otides) of one or more miRNAs with at most 1 nt mismatch,
indicating that the m6A peak regions may be targeted by
miRNAs (Figures 2B and 2C and S2A–S2D). Further analysis
revealed that 92%–96% of the m6A peaks could pair with
miRNAs with relatively strict alignment criteria. In particular,
the RRACH motif region of m6A peaks could potentially pair
with 482 miRNAs. The enrichment of miRNA binding sites
Figure 1. Dynamic m6A Modification among Cell Types
(A and B) Representative Gene Ontology (GO) terms of the biological process category enriched by transcripts stably expressed in all cell types with (A) or without
(B) m6A modifications.
(C and D) Distribution of m6A peaks along cell-type-consistently expressed transcripts with identical (C) or variable (D) modification profiles among cell types.
Each horizontal line represents one transcript. Blue lines represent m6A peaks within each sequence region. TcSS, transcription start sites; 50 UTR, 50 un-
translated region; CDS, coding sequence; TsTS, translation termination sites; 30 UTR, 30 untranslated region.
(E) Expression profile of cell-type-specifically expressed transcripts (left) and the distribution of m6A peaks on each transcript (right). Blue lines represent m6A
peaks within each sequence region. Names of selected cell-type-specific genes are listed.
See also Figure S1, Table S1, Table S2, Table S3, Table S4, Table S5, and Table S6.
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Figure 2. m6A Peaks as Putative miRNA Target Sites
(A) The most common sequence motif among m6A peaks in each cell type.
(B) Pairing situation between the most common m6A motif with the sequences of corresponding miRNAs. Full-size letters in miRNAs represent ‘‘seed se-
quences.’’
(C) Pairing situation of two selected m6A motifs in NSCs with corresponding miRNAs. Full-size letters in miRNAs represent seed sequences.
(D) The percentage of m6A-enriched motifs targeted by miRNAs among all m6A-enriched motifs versus the percentage of simulated motifs targeted by miRNAs
among all simulated motifs. Error bars represent SD of 500 simulated experiments.
***p < 2.2e16 by Student’s t test. See also Figure S2 and Table S6.among m6A enriched motifs was remarkably higher than those
of the randomly simulated motifs (Figure 2D).
To investigate whether these m6A-targeting miRNAs were
indeed expressed in corresponding cells, we quantified miRNA
expression using small RNA-seq in ESCs. Of the 1,866 m6A-
targeting miRNAs, 818 were detected to be expressed in
ESCs. These expressed miRNAs had a significant tendency
to target m6A peaks as compared to control peaks (71% versus
39%, p < 2.2e16, Fisher’s exact test). The consistency be-
tween small RNA-seq data and cellular miRNA abundance
was validated by qRT-PCR on 12 randomly selected miRNAs
(including 2 cell-type-specific ones) (Figures S2E and S2F).
Using the same criteria, 75% of m6A peaks were identified as
potential targets of expressed miRNAs in HeLa cells using
the published m6A data (Wang et al., 2014a), indicating the
conservation of miRNA regulation on m6A between human
and mouse.
Formation of m6A Depends on Dicer, but Not Argonaute
To investigate whether miRNAs were indeed involved in the
regulation of m6A, we examined the effects of key miRNA
biogenesis proteins on cellular m6A abundance. Knocking
downDicer, the endonuclease responsible for producing mature292 Cell Stem Cell 16, 289–301, March 5, 2015 ª2015 Elsevier Inc.miRNAs, significantly reduced cellular m6A abundance in both
mouseNSCs (Figures 3A and 3B and S3A) and humanHeLa cells
(Figures 3D and 3E and S3B). Conversely, overexpressing Dicer
increased the m6A modification level (Figures 3G, 3H, 3J, 3K,
and S3C). In all these experiments, expected Dicer and miRNA
expression changes were detected, whereas the protein abun-
dance of neither m6A methyltransferase METTL3 nor demethy-
lases FTO and ALKBH5 were affected (Figures 3C, 3F, 3I, 3L,
and S3D), suggesting that Dicer-induced m6A abundance
change was not achieved by the alteration of the quantity of
m6A methyltransferase or demethylases in cells.
Argonaute (AGO) proteins are the key components of known
miRNA functional pathways and mediate the binding of miRNAs
to their target mRNAs (Bartel, 2004; Cenik and Zamore, 2011;
Meister, 2013; Rand et al., 2005). We further examined whether
AGO proteins participate in the regulation of m6A formation. The
genomes of human and mouse each encode four types of AGO
clade proteins (AGO1–AGO4) with miRNA binding ability (Cenik
and Zamore, 2011; Meister, 2013). Unexpectedly, knocking
down individual AGO expression in HeLa cells had no effect on
m6A abundance (Figures S3E–S3G). To avoid functional redun-
dancy, we further used mixed siRNAs to knock down all four
AGO genes in mouse NSCs and human HeLa cells. Neither
(legend on next page)
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experiment resulted in an exhibited abundance change of total
m6A (Figures 3M, 3N, and S3H–S3K), ruling out the involvement
of AGO proteins in regulating m6A formation.
miRNAs Affect the Abundance of m6A at Corresponding
Target Sites
To investigate whether miRNAs indeed function in regulating
m6A formation, we overexpressed a few randomly selected
miRNAs with sequences pairing to m6A peak regions in mouse
NSCs, and we observed significantly increased m6A abun-
dance at the corresponding miRNA target sites (Figure 4A up-
per panel and Figures S4A and S4C). Conversely, repressing
the expression of miRNAs by antagomirs significantly reduced
m6A abundance (Figure 4B left panel and Figures S4E and
S4G). The expression of target genes (Figure 4A lower panel
and Figure 4B right panel) as well as m6A methyltransferase
METTL3 and demethylases ALKBH5 and FTO (Figures S4B,
S4D, S4F, and S4H) remained unaffected in these experi-
ments, suggesting that the abundance change of m6A was
not caused by altered expression of target genes or m6A regu-
lating enzymes. Consistently, overexpression or knockdown
miRNAs (miR-423-3p and miR-1226-3p) also increased or
decreased m6A abundance in human HeLa cells (Figures 4C
and S4I).
To investigate whether miRNAs are capable of mediating
the ab initio formation of m6A, we mutated three nucleotides
in the 50 2-8 nt region (seed sequence ofmiRNAs) of fourmiRNAs,
namely miR-330-5p, miR-668-3p, miR-1224-5p, and miR-1981-
5p, to make the mutated miRNAs pairing with mRNA regions
originally without m6A peaks. Consistent results from six indi-
vidual loci in mouse NSCs demonstrated that overexpression
of the mutated miRNAs indeed caused the formation of m6A
at the designed target sites, whereas regions not targeted by
the mutated miRNAs had no m6A abundance change (control:
KIF1B and control:SCD2) (Figures 4D and S4J). Due to the
mutations, some m6A peaks originally targeted by endogenous
miRNAs were no longer targeted by the mutated ones, and no
m6A abundance change was detected at these sites either
(i.e., control:SSRP1 was targeted by miR-1224-5p, but not its
mutant) (Figures 4D and S4J). These results demonstrated that
miRNAs are capable of inducing de novo m6A methylation via
a sequence-dependent manner.
miRNAs Modulate METTL3 Binding to mRNAs
The ab initio induction of m6A methylation by mutated miRNAs
drove us to speculate that miRNAs may regulate the interaction
between METTL3 and mRNAs. To test this hypothesis, we firstFigure 3. Cellular m6A Abundance Is Regulated by Dicer, but Not AGO
(A and D) m6A dot blot of the control and Dicer knockdown mouse NSCs (A) a
and (D), respectively. (C and F) Western blot analysis for protein abundance
and demethylases (FTO and ALKBH5) in mouse NSCs (C) and human HeLa c
loading control. (G and J) m6A dot blot of the control and Dicer overexpression
abundance in (G) and (J), respectively. (I and L) Western blot analysis for prote
human HeLa cells (L) transfected with vectors containing exogenous Myc-tag
b-Tubulin is used as a loading control. (M and N) Dot blot assay showing th
and human HeLa cells (N).
Values and error bars in all bar plots represent the mean and standard d
0.001 by Student’s t test. See also Figure S3 and Table S6.
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the subcellular localization of METTL3, as it has been shown
that METTL3 locates and functions at nuclear speckles (Liu
et al., 2014; Ping et al., 2014; Wang et al., 2014b). Knocking
down Dicer significantly reduced the nuclear staining density
of METTL3 in human HeLa cells (Figures 5A and 5B). Further ex-
amination using ASF (a nuclear speckle marker) staining re-
vealed that the nuclear speckle localization of METTL3 was
indeed disrupted in Dicer knockdown HeLa cells (Figure 5C),
whereas the METTL3 abundance in both nucleus and cytoplasm
almost remained unchanged (Figures 5D and S5A). Co-immuno-
precipitation assay revealed that Dicer did not associate with
METTL3 (Figures S5B and S5C), ruling out a potential physical
interaction between METTL3 and Dicer. Taken together, these
results indicated that Dicer regulates the nuclear speckle locali-
zation of METTL3.
We next performed Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) to
examine the amount of RNA associated with METTL3. Intrigu-
ingly, upon Dicer depletion, the amount of RNA crosslinked to
Myc-tagged METTL3 was significantly reduced in human HeLa
cells (Figures 5E and 5F). To further investigate whether the bind-
ing of METTL3 on mRNAs could be altered by individual miRNAs
processed by Dicer, we performed an RNA immunoprecipitation
(RIP) assay with METTL3 antibody to precipitate endogenous
METTL3 and its associated mRNAs from HeLa cells, after the
overexpression ofmiR-423-3p andmiR-1226-3p or their antago-
mirs. In concert with the results of Dicer manipulation, overex-
pressing miRNAs significantly increased the amount of mRNAs
associatedwithMETTL3, whereas downregulatingmiRNA abun-
dance by antagomirs significantly reduced METTL3 binding
on mRNAs (i.e., DGCR2 and TUBB4B, targeted by miR-423-3p
and miR-1226-3p, respectively) in HeLa cells (Figures 5G and
5H). Consistently, the amounts of METTL3-crosslinked total
RNAs (Figure 5I) and mRNAs (i.e., TCF4 and RPS13) targeted
by designed miRNAs (Figures 5J and S5D) were also altered in
mouse NSCs when manipulating Dicer or corresponding miR-
NAs, respectively. In both the mouse and human experiments,
the abundance of METTL3-bound mRNAs not targeted by the
designed miRNAs was not altered (i.e. TXNRD1 and CTNNA1
in Figure 5G; EEF1A1 in Figure 5J). Collectively, these results
showed that miRNAs regulate them6Amethyltransferase activity
of METTL3 by modulating its binding to mRNAs.m6A Actively Promotes Cell Reprogramming Efficiency
To investigate whether m6A of mRNAs plays roles in cell fate
determination, we resorted to the iPSC technology to examinend human HeLa cells (D). (B and E) Quantification of m6A abundance in (A)
of miRNA processing enzyme Dicer and m6A methyltransferase (METTL3)
ells (F) transfected with siRNAs for Dicer for 48 hr. b-Tubulin is used as a
mouse NSCs (G) and human HeLa cells (J). (H and K) Quantification of m6A
in abundance of Dicer, METTL3, FTO, and ALKBH5 in mouse NSCs (I) and
ged Dicer (Myc-Dicer). Endogenous Dicer expression is labeled as ‘‘Dicer.’’
e amount of m6A in the control and Ago1–4 knockdown mouse NSCs (M)
eviation (SD) of three independent experiments. **p < 0.01 and ***p <
(legend on next page)
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the effects of m6A on cell reprogramming. We first overex-
pressed human Myc-METTL3 into mouse embryonic fibro-
blasts (MEFs) expressing the four Yamanaka factors (Oct4,
Sox2, Klf4, and c-Myc). Overexpression of METTL3 in MEFs
increased m6A abundance (Figure S6A left panels and Fig-
ure S6B) and significantly improved the reprogramming
efficiency, with the number of obtained iPSC colonies (Oct4::
GFP-positive and AP-positive) in the METTL3 overexpression
experiment almost double that of the control (Figures 6A and
6B). Enhanced expression of key pluripotent factors, such as
Oct4, Sox2, and Nanog, was also observed in METTL3-overex-
pressing cells (Figure 6C). Conversely, inhibiting m6A formation
by knocking down METTL3 expression using siRNAs during the
reprogramming process resulted in reduced iPSC colony
numbers as well as decreased pluripotent gene expression
(Figures 6D–6F, Figure S6A right panels, and Figure S6C).
Decreased m6A abundance and iPSC colony numbers were
also observed with the addition of cycloleucine, a competitive
inhibitor of methionine adenosyltransferase (Finkel and Groner,
1983), during the reprogramming process (Figures S6D–S6F).
Furthermore, overexpression of human Myc-METTL3 insensi-
tive to mouse METTL3 siRNAs in mouse METTL3 knockdown
MEFs successfully rescued the reprogramming efficiency
(Figures 6D–6F, Figure S6A right panels, and Figure S6C).
These data indicated that m6A is required for MEF reprogram-
ming to pluripotency and can promote the reprogramming
efficiency.
DISCUSSION
Increasing lines of evidence have shown that m6A modification
may play pivotal physiological functions in regulating RNA
metabolism and various biological processes (Bodi et al.,
2012; Bokar, 2005; Fustin et al., 2013; Geula et al., 2015; Jia
et al., 2011; Liu et al., 2014; Ping et al., 2014; Schwartz et al.,
2013; Wang et al., 2014a, 2014b; Zhao et al., 2014; Zheng
et al., 2013; Zhong et al., 2008). With the advances of m6A-
seq technology, the basic features of m6A modification have
been characterized in some tissues and cell lines of mouse
and human (Batista et al., 2014; Dominissini et al., 2012; Fustin
et al., 2013; Meyer et al., 2012; Schwartz et al., 2013; Wang
et al., 2014b). Yet the dynamics of m6A among different cell
types and its regulatory mechanisms are still largely unknown.
Here we reported cross cell-type comparison of m6A profiles
using mouse pluripotent and differentiated cell lines. We iden-
tified transcripts with cell-type-dependent common or specific
m6A modifications and revealed the dynamic changes of m6AFigure 4. m6A Is Regulated by miRNAs
(A) qRT-PCR showing the m6A changes at predicted target sites of overexpressed
genes (lower panel) in mouse NSCs.
(B) qRT-PCR showing the m6A changes at predicted target sites of selected miR
(right panel) in mouse NSCs with selected miRNAs knocked down by antagomir
(C) qRT-PCR showing the m6A changes at predicted target sites of overexpress
modified target genes (right panel) in human HeLa cells.
(D) qRT-PCR showing the m6A changes at predicted target sites of four artificial
genes (lower panel) in mouse NSCs.
Values and error bars in all bar plots represent the mean and SD of three indepe
See also Figure S4 and Table S6.
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These results will provide clues for further functional studies
of m6A modification.
miRNAs are a group of important post-transcriptional regu-
lators in eukaryotes. Two previous reports discussed that the
presence of m6A may affect the binding of miRNAs to target
mRNAs (Meyer et al., 2012; Wang et al., 2014b), but whether
miRNAs have direct regulatory roles in the formation of m6A
has not been explored yet. Here, we showed that the overall
cellular m6A abundance and m6A on individual mRNAs can be
altered by the modulation of the expression of the miRNA
biogenesis enzyme Dicer or miRNAs. In addition, overexpres-
sion of miRNA mutants creates m6A methylation ab initio on
originally unmethylated mRNA sequences via a sequence-
dependent mechanism. We have further found that the function
of miRNAs in regulating m6A is achieved by the mediation of
the binding of m6A methyltransferase METTL3 to mRNAs. These
results reveal the functions of miRNAs in regulating the forma-
tion of m6A, and they also partially explain the site selection
mechanism of m6A.
As the key effector proteins of the miRNA functional cascade,
AGO proteins have been shown to bind to miRNAs and help
miRNAs to execute their functions. However, our results showed
that in both human and mouse cells, none of the AGO1–AGO4
proteins were involved in miRNA-mediated m6A regulation. It is
likely that miRNAs associate with proteins other than AGOs to
regulate m6A formation. Given the presence of a large number
of RNA binding proteins with unknown functions, finding the
miRNA binding proteins involved in m6A modification remains
challenging and needs further investigation.
The physiological roles of m6A modification in cell fate
determination are still largely unknown so far. By examining the
functions of m6A in regulating cell reprogramming using the
iPSC technology, we have revealed a positive role of m6A in
regulating cell reprogramming. Such effects were accompanied
by altered expression of key pluripotent factors, such as Oct4,
Sox2, and Nanog. Consistently, two recent studies reported
that proper formation of m6A is required for maintaining the
ground state of human and mouse ESCs (Batista et al., 2014;
Geula et al., 2015), which is in concert with the function of m6A
in promoting the iPSC process identified in this work. All these
suggested that proper m6A formation is essential for differenti-
ated cells to regain pluripotent property.
In summary, our study provided the m6A profiles in mouse
pluripotent and differentiated cell lines and identified the cell-
type-specific and several other features of m6A modification.
We have demonstrated that miRNAs are involved in themiRNAs (upper panel) and the expression changes of the m6Amodified target
NAs (left panel) and the expression changes of the m6A modified target genes
s.
ed or repressed miRNAs (left panel) and the expression changes of the m6A
miRNAs (upper panel) and the expression changes of the m6A modified target
ndent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student’s t test.
Figure 5. miRNAs Affect METTL3 Binding to RNAs
(A) Immunofluorescence analysis of FAM-labeled Dicer-siRNA (green), METTL3 (red), and DAPI (blue, cell nuclei) in Dicer knockdown and control HeLa cells.
Scale bar, 7.5 mm.
(B) Quantification of fluorescence intensity of METTL3 in (A). n = 101 cells for each sample.
(C) Immunofluorescence analysis of METTL3 (red), ASF (green, nuclear speckles), and DAPI (blue, cell nuclei) in Dicer knockdown and control HeLa cells. Scale
bar, 5 mm.
(D) Western blot (left panel) and quantitative analysis (right panel) of nuclear and cytoplasmic fractions of METTL3 in Dicer knockdown and control HeLa cells.
PARP-1 and b-Tubulin are used as nuclear and cytoplasmic markers, respectively.
(E and F) Blot (E) and quantitative analysis (F) of RNAs pulled down by Myc-METTL3 in the control and Dicer knockdown HeLa cells.
(legend continued on next page)
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regulation of m6A formation in both mouse and human cells
by their mediation of the binding of METTL3 on mRNAs. These
findings revealed a role of miRNAs in regulating mRNA epitran-
scriptomic modification in eukaryotes. Our findings on the
functions of m6A in cell reprogramming also suggested that
modulating m6A may serve as a strategy to regulate cell
reprogramming.
EXPERIMENTAL PROCEDURES
Generation of iPSCs and Reprogramming Efficiency Evaluation
Generation of pluripotent iPSC lines was performed as described previously
(Wernig et al., 2008). MEFs were isolated from E13.5 embryos heterozygous
for the Oct4::GFP transgenic allele, as previously described (Huangfu et al.,
2008), and cultured under established iPSC conditionswith the four Yamanaka
factors (Oct4, Sox2,Klf4, and c-Myc) expressed. The efficiency of iPSC forma-
tion is estimated according to the number of Oct4-GFP-positive colonies.
GFP-positive colonies after 15 days of reprogramming were trypsinized and
then analyzed using a FACS Calibur (BD Biosciences). A minimum of 10,000
events were recorded. Detection of alkaline phosphatase, which is an indicator
of undifferentiated ESCs, was carried out after 15 days of reprogramming. The
number of iPSC colonies per well was counted in triplicates. The expression of
key pluripotent factors Oct4, Sox2, and Nanog was detected by qRT-PCR.
m6A-seq Library Generation and Sequencing
m6A immunoprecipitation and library construction procedure were modified
from published procedure (Meyer et al., 2012). In brief, fragmented and ethanol
precipitated mRNA (3 mg) from different cell lines was incubated with 5 mg
of anti-m6A polyclonal antibody (Synaptic Systems, 202003) in IPP buffer
(150 mM NaCl, 0.1% NP-40, and 10 mM Tris-HCl [pH 7.4]) for 2 hr at 4C.
The mixture was then immunoprecipitated by incubation with 50 ml protein-A
beads (Sigma, P9424) at 4C for an additional 2 hr. After being washed three
times, bound RNA was eluted from the beads with 0.5 mg/ml N6-methylade-
nosine (BERRY & ASSOCIATES, PR3732) in IPP buffer and then extracted
by Trizol. The remaining RNA was re-suspended in H2O and used for library
generation with mRNA sequencing kit (Illumina). Sequencing was carried out
using the RNA-seq method as described in the Supplemental Procedures.
Sequencing Data Processing and m6A Peak Calling
Sequence reads were mapped to the mouse reference genome (mm9) using
TopHat (version 2.0.4) with a RefSeq-based transcript index (Kim et al.,
2013). For RNA-seq analysis, the expression of transcripts was quantified as
Fragments Per Kilobase of transcript per Million mapped reads (FPKM) and
estimated by Cufflinks (version 2.0.2) (Trapnell et al., 2013). Cell-type-specific
transcripts were identified using the Shannon entropy of each transcript
following the previously reported method (Xie et al., 2013). To identify m6A-
enriched regions (m6A peaks), the normalized values of Reads Per Kilobase
of genome per Million mapped reads (RPKM) of both mapped m6A-seq reads
and RNA-seq reads were calculated and used. m6A peaks were identified by
the comparison of the read abundance between m6A-seq and RNA-seq sam-
ples of the same loci with a method modified from a previous report (Meyer
et al., 2012). Briefly, the entire mouse genome was divided into 25 nt bins
and the numbers of both m6A-seq reads and RNA-seq reads (used as control)
mapped to each bin were counted and compared. Bins with statistically
enriched m6A-seq reads as compared to the RNA-seq reads (adjusted(G) METTL3-RIP-qRT-PCR showing the changes of METTL3 binding at predicted
(anti-miR) miRNAs. Non-target regions (TXNRD1 and CTNNA1) of the operated m
(H) Western blot analysis showing equal amounts of METTL3 in control cells, miR
and comparable METTL3 immunoprecipitation efficiency (right panel).
(I) Blot analysis of RNAs pulled down by Myc-METTL3 in the control and Dicer k
(J) METTL3-RIP-qRT-PCR showing the changes of METTL3 binding at predicted
miR) miRNAs. A non-target region of miRNAs (EEF1A1) is used as a control.
Values and error bars in all bar plots represent the mean and SD of three indepe
See also Figure S5 and Table S6.
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were identified and concatenated adjacently. m6A-seq reads enriched regions
with lengths no less than 75 nts were kept as m6A peaks. m6A peaks longer
than 200 nts were split into 200 nt smaller peaks during the total m6A peak
counting process. Using the same criteria, regions statistically enriched for
RNA-seq reads were chosen as the control peaks. The m6A peaks of human
HeLa cells were identified using the same criteria with data from the GEO
database GSE46705.
Motif Identification among m6A Peaks
Sequence motifs enriched in m6A peaks were identified by HOMER with m6A
peaks as the target sequences and control peaks as the background using
default parameters (Heinz et al., 2010) and visualized using WebLogo (Crooks
et al., 2004). The enriched motifs were randomly shuffled to generate 500
groups of simulated motifs in each cell type and were used for specificity
analysis.
Relationship Analysis of miRNAs with m6A Peaks
Mouse mature miRNA sequences were downloaded from miRBase (Release
20 with 1,908 mouse miRNA sequences) (Kozomara and Griffiths-Jones,
2011), then compared with the motifs identified by HOMER or randomly simu-
lated motifs using in-house scripts. miRNAs with seed regions (50 2-8 nts)
reverse complementarily pairing (with at most one mismatch) to m6A motifs
were selected. To compare miRNA sequences with all m6A peaks, the
entire sequences of identified m6A peaks and control peaks were extracted
and paired with the miRNA sequences using miRanda software with
‘‘sc 155 en 20’’ and other default settings as parameters (Enright et al.,
2003). m6A peak sequences and control peak sequences that passed the
above criteria were identified as miRNA-targeted peaks.
m6A Manipulation during the iPSC Process
Under the iPSC induction condition as described above, the following exper-
iments were carried out from the first day of reprogramming. In the METTL3
overexpression experiments, 5 mg of plasmids expressing pCMV-Myc-
METTL3 and 5 mg pCMV-Myc-control plasmids were transfected into MEFs
using Lipofectamine 2000 kit (Invitrogen) three times every 3 days. In the
METTL3 knockdown experiment, 75 nM siRNAs targeting METTL3 and
75 nM control siRNAs were transfected into MEFs using Lipofectamine
RNAiMAX (Invitrogen) four times every 3 days. In the rescue experiment,
5 mg of plasmids expressing pCMV-Myc-hMETTL3 (Ping et al., 2014), which
does not contain the target site of mouseMETTL3 siRNAs, and 5 mg of control
plasmids were transfected into the METTL3 knockdown MEFs three times
every 3 days. In the chemical m6A inhibition experiments, 20 mM cycloleucine
was added to the culture medium of MEFs once per day for 10 days.
Statistical Analysis
Student’s t test was used for all statistical analyses for experimental results
(unless stated otherwise).
See Supplemental Experimental Procedures for a full description of the
methods.
ACCESSION NUMBERS
Sequencing data generated by this work have been deposited into the Gene
Expression Omnibus (GEO; accession number GSE52125).target sites (DGCR2 and TUBB4B) of overexpressed (OE-miR) and repressed
iRNAs were used as controls.
NA-overexpression HeLa cells, and miRNA-knockdown HeLa cells (left panel)
nockdown mouse NSC cells. b-Tubulin is used as a loading control.
target sites (TCF4 and RPS13) of overexpressed (OE-miR) and repressed (anti-
ndent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 by Student’s t test.
Figure 6. Modulating m6A Abundance by METTL3 Regulates Cell Reprogramming
(A) Morphology (left panel) and quantitative (right panel) analysis of Oct4-GFP-positive clones among reprogrammed MEFs with control vector (OE-Control) and
mouse METTL3 overexpression (OE-METTL3).
(B) AP-positive clones among reprogrammed MEFs with control vector (OE-Control) and mouse METTL3 overexpression (OE-METTL3).
(C) The expression levels (detected by qRT-PCR) of endogenous Oct4, Sox2, and Nanog in cells during the reprogramming process of MEFs with the control
vector (OE-Control) and mouse METTL3 overexpression (OE-METTL3).
(D) Morphology (left panel) and quantitative (right panel) analysis of Oct4-GFP-positive clones among reprogrammed MEFs with control siRNAs (si-Control),
siRNAs for mouse METTL3 (si-mMETTL3), and human Myc-METTL3 rescue (si-mMETTL3+OE-hMETTL3).
(E) AP-positive clones among reprogrammedMEFs with control siRNAs (si-Control), siRNAs for mouseMETTL3 (si-mMETTL3), and humanMyc-METTL3 rescue
(si-mMETTL3+OE-hMETTL3).
(F) The expression levels (detected by qRT-PCR) of endogenousOct4, Sox2, and Nanog in cells during the reprogramming process of MEFs with control siRNAs
(si-Control), siRNAs for mouse METTL3 (si-mMETTL3), and human Myc-METTL3 rescue (si-mMETTL3+OE-hMETTL3).
Values and error bars in all plots represent the mean and SD of three independent experiments. *p < 0.05 by Student’s t test. See also Figure S6 and Table S6.SUPPLEMENTAL INFORMATION
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